申请人:THE GENERAL HOSPITAL CORPORATION
公开号:US20170334842A1
公开(公告)日:2017-11-23
Provided herein are compounds of the formula (IV):
as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful as MITF inhibitors, MITF pathway inhibitors and for the treatment of cancer.